Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.

Bibliographic Details
Main Authors:	Jarius, S, Paul, F, Franciotta, D, Aktas, O, Hohlfeld, R, Zipp, F, Vincent, A
Format:	Journal article
Language:	English
Published:	2007

Similar Items

NMO-IgG in the diagnosis of neuromyelitis optica.
by: Jarius, S, et al.
Published: (2007)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
by: Littleton, E, et al.
Published: (2006)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
by: Akman-Demir, G, et al.
Published: (2008)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
by: Jarius, S, et al.
Published: (2008)

Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica
by: Tarso Adoni, et al.
Published: (2008-06-01)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
by: Jarius, S, et al.
Published: (2007)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
by: Paul, F, et al.
Published: (2007)

Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG
by: Min, J, et al.
Published: (2010)

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro
by: Jarius, S, et al.
Published: (2007)

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY
by: Jacob, A, et al.
Published: (2009)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
by: Downer, J, et al.
Published: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
by: Downer, J, et al.
Published: (2012)

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica
by: Jacob, S, et al.
Published: (2007)

Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis
by: Jarius, S, et al.
Published: (2007)

A novel sensitive assay for aqueporin-4 antibodies (NMO-IgG)
by: Waters, P, et al.
Published: (2007)

Neuromyelitis optica IgG causes placental inflammation and fetal death.
by: Saadoun, S, et al.
Published: (2013)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
by: Narayanan Unni, et al.
Published: (2013-01-01)

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
by: Juryńczyk, M, et al.
Published: (2015)

Neuromyelitis optica IgG causes placental inflammation and fetal death in mice
by: Saadoun, S, et al.
Published: (2013)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
by: Saadoun, S, et al.
Published: (2013)

MOG-IGG IN NMO AND NMO-LIKE DISORDERS
by: Luppe, S, et al.
Published: (2014)

Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.
by: Kim, S, et al.
Published: (2011)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
by: Collongues, N, et al.
Published: (2013)

Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO.
by: Min, J, et al.
Published: (2012)

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica.
by: Jarius, S, et al.
Published: (2008)

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance
by: Jarius Sven, et al.
Published: (2010-09-01)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
by: Jacob, S, et al.
Published: (2008)

Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives
by: Giulia Ceglie, et al.
Published: (2020-07-01)

Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacks
by: Edouard Januel, et al.
Published: (2024-01-01)

Neuromyelitis Optica Spectrum Disorders (NMOSD); Diagnostic criteria (ORP-56)
by: Maryam Poursadeghfard
Published: (2023-01-01)

Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain
by: Papadopoulos, M, et al.
Published: (2011)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
by: Jarius, S, et al.
Published: (2008)

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
by: Waters, P, et al.
Published: (2012)

Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks
by: Murchison, A, et al.
Published: (2013)

Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders
by: Shiyu Gao, et al.
Published: (2024-03-01)

Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder
by: Eun Bin Cho, et al.
Published: (2024-03-01)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
by: Jarius, S, et al.
Published: (2008)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
by: Jarius, S, et al.
Published: (2008)

The borderland of neuromyelitis optica.
by: Matthews, L, et al.
Published: (2009)

Neuromyelitis optica
by: Jacob Anu, et al.
Published: (2007-01-01)